CD8A and head and neck squamous cell carcinoma: This was confirmed by a similar approach in HNSCC demonstrating reduced numbers and activation status of CD8+ T-cells as well as myeloid cells with increasing [18F]FDG uptake (128), and renal cell carcinoma (129, 130).